Knox Bell concentrates his legal practice in the areas of business and corporate, biotechnology and life sciences, licensing, strategic alliances, health care and nonprofit research institution. Mr. Bell has been practicing with DLA Piper in these areas since 1968.

Legal 500 praised Mr. Bell for being "not only extremely knowledgeable with respect to legal and contractual issues in the pharmaceuticals and biotech industry, but has proven to be a skilled negotiator on our behalf in contract negotiations with legal counsel from large pharma companies."

Mr. Bell has recently represented:

• Entrepreneurs in establishing and financing new businesses in areas of technology, biosciences, products and services
• Companies in negotiating and structuring agreements for licensing, research collaboration, research funding agreements, strategic alliances and distribution agreements
• Life science companies in negotiating, structuring and drafting agreements for clinical trials, CRO services, manufacture and supply of products and product distribution
• Companies in negotiating and structuring merger, acquisition and sale transactions
• Nonprofit research organizations for corporate organization and operations
• Universities, research institutes and companies for technology licensing, research funding and spinout commercial ventures
• Sellers and buyers in commercial real estate sales transactions
• Directors and boards in the areas of good corporate governance